D Concordet
Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"
Concordet, D; Gandia, P; Montastruc, J L; Bousquet-Mélou, A; Lees, P; Ferran, A; Toutain, P L
Authors
P Gandia
J L Montastruc
A Bousquet-Mélou
P Lees
A Ferran
P L Toutain
Citation
Concordet, D., Gandia, P., Montastruc, J. L., Bousquet-Mélou, A., Lees, P., Ferran, A., & Toutain, P. L. (in press). Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?". Clinical Pharmacokinetics, https://doi.org/10.1007/s40262-019-00780-2
Journal Article Type | Letter |
---|---|
Acceptance Date | Jun 1, 2019 |
Deposit Date | Jun 19, 2019 |
Publicly Available Date | Mar 29, 2024 |
Journal | Clinical Pharmacokinetics |
Print ISSN | 0312-5963 |
Publisher | Adis |
Peer Reviewed | Not Peer Reviewed |
DOI | https://doi.org/10.1007/s40262-019-00780-2 |
Public URL | https://rvc-repository.worktribe.com/output/1382025 |
Files
12178.pdf
(687 Kb)
PDF
You might also like
Biased computation of Probability of Target Attainment for antimicrobial drugs
(2023)
Journal Article
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
(2022)
Journal Article
Levothyrox® new and old formulations: are they switchable for millions of patients?
(2019)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search